IL-1α IL-1β IL-6 IL-8 TNF-α

HC (n = 89) 200.1±61.4 199.6±43.8 42.0±6.7 31.8±7.7 16.4±4.4
CP          
BT(+) (n = 12) 703.7±91.1*#$ 201.2±33.3 90.9±11.1*#$ 115.4±22.5*#$ 116.4±14.6*#$
BT(-) (n = 38) 218.7±54.1 195.6±22.1 38.6±5.6 181.0±25.2 61.5±12.4
NCP          
BT(+) (n = 4) 498.3±67.6 216.4±76.7 40.9±17.1 78.8±6.2 100.9±18.7
BT(-) (n = 46) 316.3±91.6 220.5±65.7 42.6±10.6 61.4±12.9 20.7±8.4

CP: cachectic patients. NCP: non-cachectic patients. HC: healthy controls. IL: interleukin. TNF: tumor necrosis factor.

*P < 0.05 BT(+) CP vs. HC. #P < 0.05 in BT(+) CP vs. BT(+) NCP. $P < 0.05 in BT(+) CP vs. BT(-) CP.

 

Zhang et al.Journal of Cancer Therapeutics and Research  2012 1:19DOI : 10.7243/2049-7962-1-19